Jeffrey I. Cohen

34.2k total citations · 7 hit papers
313 papers, 18.8k citations indexed

About

Jeffrey I. Cohen is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, Jeffrey I. Cohen has authored 313 papers receiving a total of 18.8k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Epidemiology, 96 papers in Oncology and 81 papers in Immunology. Recurrent topics in Jeffrey I. Cohen's work include Herpesvirus Infections and Treatments (137 papers), Viral-associated cancers and disorders (85 papers) and Cytomegalovirus and herpesvirus research (62 papers). Jeffrey I. Cohen is often cited by papers focused on Herpesvirus Infections and Treatments (137 papers), Viral-associated cancers and disorders (85 papers) and Cytomegalovirus and herpesvirus research (62 papers). Jeffrey I. Cohen collaborates with scholars based in United States, Japan and United Kingdom. Jeffrey I. Cohen's co-authors include Elliott Kieff, G. Ralph Corey, Lesley Pesnicak, F Wang, John Bartlett, Stephen E. Straus, Joan B. Mannick, Kening Wang, Xueqiao Liu and Peter D. Burbelo and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Jeffrey I. Cohen

309 papers receiving 18.5k citations

Hit Papers

Epstein–Barr Virus Infection 1987 2026 2000 2013 2000 2019 2015 2013 1987 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epstein–Barr Virus Infection
    2000 1.2k citations Jeffrey I. Cohen profile →
  2. VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
    2019 511 citations Jeonghan Kim, Luz P. Blanco et al. Science profile →
  3. Varicella zoster virus infection
    2015 500 citations Anne A. Gershon, Judith Breuer et al. profile →
  4. Herpes Zoster
    2013 499 citations Jeffrey I. Cohen profile →
  5. Extra-Intestinal Manifestations of Salmonella Infections
    1987 453 citations Jeffrey I. Cohen et al. profile →
  6. Epstein–Barr virus as a leading cause of multiple sclerosis: mechanisms and implications
    2023 128 citations Jeffrey I. Cohen et al. profile →
  7. Herpes Zoster Vaccines
    2021 117 citations Jeffrey I. Cohen et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey I. Cohen United States 71 8.2k 6.3k 5.2k 3.6k 2.9k 313 18.8k
Don Ganem United States 85 16.5k 2.0× 10.9k 1.7× 3.1k 0.6× 5.4k 1.5× 5.4k 1.9× 204 25.1k
Paul Moss United Kingdom 69 5.7k 0.7× 4.3k 0.7× 11.4k 2.2× 2.9k 0.8× 3.2k 1.1× 318 20.6k
Joseph S. Pagano United States 66 4.6k 0.6× 8.4k 1.3× 3.2k 0.6× 2.8k 0.8× 3.8k 1.3× 244 14.3k
Christian Münz Switzerland 71 6.1k 0.7× 5.4k 0.9× 11.9k 2.3× 1.2k 0.3× 4.0k 1.4× 295 19.4k
Patrick S. Moore United States 79 13.7k 1.7× 24.9k 4.0× 2.9k 0.6× 6.6k 1.8× 3.7k 1.3× 284 31.8k
Mark H. Kaplan United States 78 5.6k 0.7× 6.1k 1.0× 13.9k 2.7× 4.6k 1.2× 4.3k 1.5× 408 27.2k
Yuan Chang United States 73 12.0k 1.5× 24.1k 3.8× 3.8k 0.7× 6.2k 1.7× 3.3k 1.1× 215 32.1k
Tetsutaro Sata Japan 57 4.8k 0.6× 1.9k 0.3× 2.8k 0.5× 3.7k 1.0× 3.2k 1.1× 328 12.0k
Evelyn A. Kurt‐Jones United States 68 6.2k 0.8× 2.1k 0.3× 9.8k 1.9× 2.6k 0.7× 6.5k 2.3× 139 20.4k
Thomas F. Schulz Germany 64 6.8k 0.8× 8.5k 1.4× 2.7k 0.5× 4.2k 1.2× 1.6k 0.6× 358 14.1k

Countries citing papers authored by Jeffrey I. Cohen

Since Specialization
Citations

This map shows the geographic impact of Jeffrey I. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey I. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey I. Cohen more than expected).

Fields of papers citing papers by Jeffrey I. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey I. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey I. Cohen. The network helps show where Jeffrey I. Cohen may publish in the future.

Co-authorship network of co-authors of Jeffrey I. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey I. Cohen. A scholar is included among the top collaborators of Jeffrey I. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey I. Cohen. Jeffrey I. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Maximova, Olga A., Sarah L. Anzick, Daniel E. Sturdevant, et al.. (2025). Spatiotemporal profile of an optimal host response to virus infection in the primate central nervous system. PLoS Pathogens. 21(1). e1012530–e1012530. 2 indexed citations
2.
Kreitman, Robert J., M N Gould, Hong Zhou, et al.. (2023). COVID-19 in patients with classic and variant hairy cell leukemia. Blood Advances. 7(23). 7161–7168. 2 indexed citations
3.
Cheung, Foo, Richard Apps, Lesia Dropulic, et al.. (2022). Sex and prior exposure jointly shape innate immune responses to a live herpesvirus vaccine. eLife. 12. 6 indexed citations
4.
Casper, Corey, Lawrence Corey, Jeffrey I. Cohen, et al.. (2022). KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine. npj Vaccines. 7(1). 108–108. 35 indexed citations
5.
Venturini, Cristina, Charlotte J. Houldcroft, Arina Lazareva, et al.. (2021). Epstein–Barr virus (EBV) deletions as biomarkers of response to treatment of chronic active EBV. British Journal of Haematology. 195(2). 249–255. 4 indexed citations
6.
Burbelo, Peter D., Francis X. Riedo, Chihiro Morishima, et al.. (2020). Sensitivity in Detection of Antibodies to Nucleocapsid and Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With Coronavirus Disease 2019. The Journal of Infectious Diseases. 222(2). 206–213. 249 indexed citations
7.
Kim, Jeonghan, Luz P. Blanco, Shutong Yang, et al.. (2019). VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease. Science. 366(6472). 1531–1536. 511 indexed citations breakdown →
8.
Melani, Christopher, Mark Roschewski, Stefania Pittaluga, et al.. (2018). Phase II Study of Interferon-Alpha and DA-EPOCH+/-R in Lymphomatoid Granulomatosis. Blood. 132(Supplement 1). 785–785. 3 indexed citations
9.
Coghill, Anna E., Wei Bu, Hanh Nguyen, et al.. (2016). High Levels of Antibody that Neutralize B-cell Infection of Epstein–Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma. Clinical Cancer Research. 22(14). 3451–3457. 32 indexed citations
10.
Yamamoto, Takenobu, Mir A. Ali, Xueqiao Liu, & Jeffrey I. Cohen. (2014). Activation of H2AX and ATM in varicella-zoster virus (VZV)-infected cells is associated with expression of specific VZV genes. Virology. 452-453. 52–58. 10 indexed citations
11.
Sashihara, Junji, Yo Hoshino, Tammy Krogmann, et al.. (2011). Soluble Rhesus Lymphocryptovirus gp350 Protects against Infection and Reduces Viral Loads in Animals that Become Infected with Virus after Challenge. PLoS Pathogens. 7(10). e1002308–e1002308. 42 indexed citations
12.
Hoshino, Yo, Lesley Pesnicak, Stephen E. Straus, & Jeffrey I. Cohen. (2009). Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8+ T cells infiltrating the ganglia. Virology. 387(1). 193–199. 7 indexed citations
13.
Tang, Shuang, Andrea S. Bertke, Amita Patel, et al.. (2008). An acutely and latently expressed herpes simplex virus 2 viral microRNA inhibits expression of ICP34.5, a viral neurovirulence factor. Proceedings of the National Academy of Sciences. 105(31). 10931–10936. 142 indexed citations
14.
Wang, Kening, Susan E. Hoover, Erik K. Mont, et al.. (2007). Diverse Herpes Simplex Virus Type 1 Thymidine Kinase Mutants in Individual Human Neurons and Ganglia. Journal of Virology. 81(13). 6817–6826. 32 indexed citations
15.
Li, Qingxue, Mir A. Ali, & Jeffrey I. Cohen. (2006). Insulin Degrading Enzyme Is a Cellular Receptor Mediating Varicella-Zoster Virus Infection and Cell-to-Cell Spread. Cell. 127(2). 305–316. 120 indexed citations
16.
Cohen, Jeffrey I., Edward C. Cox, Lesley Pesnicak, Shamala Srinivas, & Tammy Krogmann. (2004). The Varicella-Zoster Virus Open Reading Frame 63 Latency-Associated Protein Is Critical for Establishment of Latency. Journal of Virology. 78(21). 11833–11840. 46 indexed citations
17.
Reddy, Sanjay M., Marshall V. Williams, & Jeffrey I. Cohen. (1998). Expression of a Uracil DNA Glycosylase (UNG) Inhibitor in Mammalian Cells: Varicella-Zoster Virus Can Replicatein Vitroin the Absence of Detectable UNG Activity. Virology. 251(2). 393–401. 27 indexed citations
18.
Moriuchi, Masako, et al.. (1995). Pseudorabies Virus EP0 Is Functionally Homologous to Varicella-Zoster Virus ORF61 Protein and Herpes Simplex Virus Type 1 ICP0. Virology. 209(1). 281–283. 21 indexed citations
19.
Cohen, Jeffrey I., et al.. (1994). Absence of Varicella-zoster Virus (VZV) Glycoprotein V Does not Alter Growth of VZV in vitro or Sensitivity to Heparin. Journal of General Virology. 75(11). 3087–3093. 43 indexed citations
20.
Cohen, Jeffrey I., et al.. (1990). Absence of T cell impairments in a unique group of anal-receptive transvestite and male prostitutes in Israel.. PubMed. 26(1). 26–31. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Don Ganem Breakdown of academic impact, for papers by Paul Moss Breakdown of academic impact, for papers by Joseph S. Pagano Breakdown of academic impact, for papers by Christian Münz Breakdown of academic impact, for papers by Patrick S. Moore Breakdown of academic impact, for papers by Mark H. Kaplan Breakdown of academic impact, for papers by Yuan Chang Breakdown of academic impact, for papers by Tetsutaro Sata Breakdown of academic impact, for papers by Evelyn A. Kurt‐Jones Breakdown of academic impact, for papers by Thomas F. Schulz
Rankless by CCL
2026